Group 1 - The core point of the article highlights the signing of a contract for a 120Ah battery cell production project between Penghui Energy and Zhengyang County, which signifies a significant investment and job creation in the region [1] - The total investment for the project is 2.1 billion yuan, covering an area of 120,000 square meters, with an annual production capacity of 13.5 GWh and an expected annual output value of 5 billion yuan, creating approximately 900 new jobs [1] - The first phase of the project, which commenced on January 10, has a total investment of 1 billion yuan, with a daily production capacity of 30,000 small power batteries and 500,000 supercapacitor lithium-ion batteries, leading to an annual production capacity of 1.5 to 2 GWh and an expected annual output value of 1 billion yuan, directly providing 200 jobs [1] Group 2 - The project is noted for its fully automated production line efficiency of 25 ppm, which is considered leading in the domestic industry [5] - The establishment of this project fills a gap in high-end lithium battery production in Zhengyang County, marking the first time this traditional agricultural county has developed a core in the new energy industry [5] - The project is seen as a strategic move for Penghui Energy to seize a competitive advantage while also supporting the local economy and facilitating the transformation of Zhengyang County into a new energy hub [5]

Core Viewpoint - Penghui Energy is solidifying its leading position in the global energy storage market through continuous capacity expansion, as evidenced by its recent investment plans [3][4]. Investment Plans - On February 12, Penghui Energy announced two major investment projects: a 120Ah cell production project in Zhengyang, Henan, with an investment of 2.1 billion yuan, and a 587Ah and 120Ah battery production project in Yicheng, Zhumadian, with an investment of 1.2 billion yuan [3]. - The Zhengyang project will establish four production lines for 120Ah batteries, while the Zhumadian project will set up one production line for 587Ah batteries and one for 120Ah batteries, focusing on high-performance battery product development and production [3]. Strategic Goals - The purpose of these projects is to optimize capacity layout, meet future business development and market expansion needs, and enhance the company's business influence and overall competitiveness [3]. Funding Sources - The funding for these projects will come from the company's own or self-raised funds, with plans to use a combination of equity and debt financing methods, including but not limited to bank financing, convertible bonds, preferred shares, and private placements [3][4]. Current Production Bases - Currently, Penghui Energy has established production bases in multiple locations, including Guangzhou, Zhuhai, Zhumadian, Changzhou, Liuzhou, Foshan, Quzhou, Qingdao, and even in Vietnam [4].

鹏辉能源（300438）(300438.SZ)发布公告，为进一步优化公司产能布局，增强公司业务的影响力和综 合竞争力，公司拟在河南省正阳县投资建设年120Ah电芯生产项目，计划总投资金额21亿元。 本次投资符合公司的战略发展规划，为进一步优化公司产能布局，增强公司业务的影响力和综合竞争 力，满足公司未来业务发展和市场拓展的需要，对公司的产业布局及未来发展具有积极作用和深远意 义。 ...

格隆汇2月12日丨鹏辉能源(300438.SZ)公布，为进一步优化公司产能布局，增强公司业务的影响力和综 合竞争力，公司拟在河南省正阳县投资建设年120Ah电芯生产项目，计划总投资金额21亿元。项目拟建 设4条120Ah电池生产线，生产线聚焦高性能电池产品的研发与生产。 ...

以下是第一财经对一些重要公告的汇总，供投资者参考。 【品大事】 ST新华锦：公司股票预计将自2026年2月26日起被上交所实施停牌 ST新华锦晚间公告，公司责令改正事项的期限将于2026年2月25日届满。截至本公告披露日，公司间接控股股东新华锦集团有限公司及其关联方累计归还占 用资金0元。公司如未在期限届满前完成整改，公司股票预计将自2026年2月26日起被上交所实施停牌，停牌期限不超过2个月。提醒投资者充分关注公司股 票停牌、被实施退市风险警示等退市相关风险。 江钨装备：筹划2026年度向特定对象发行A股股票事项 双良节能晚间公告，公司于2025年10月25日和2026年1月9日签订的3项海外订单总金额约170万欧元，约合人民币1392.3万元，占公司2024年度经审计营业收 入的0.11%，对公司经营业绩无重大影响。订单为高效换热器，用于SpaceX星舰发射基地扩建配套的燃料生产系统。公司为国际工业气体企业的燃料项目供 应换热器，间接参与相关商业航天项目，未直接与SpaceX合作。 鹏辉能源：拟在河南省正阳县投资21亿元建设120Ah电芯生产项目 鹏辉能源晚间公告，为进一步优化公司产能布局，增强公司业务的 ...

Group 1 - Fuda Alloy's controlling shareholder Wang Dawu plans to reduce his stake by up to 3% of the company's total shares, amounting to a maximum of 406.34 million shares, due to personal funding needs [1] - ST Songfa's subsidiary signed contracts for the construction of 17 vessels, with a total contract value between 1.6 billion to 1.8 billion USD [2] - Pairui Co. signed a technical cooperation agreement with a university to develop large-capacity power semiconductor devices and related power electronic modules, effective for three years [3] Group 2 - Shuangliang Energy indirectly participates in commercial aerospace projects, supplying heat exchangers for SpaceX's fuel production system, with orders totaling approximately 1.39 million CNY [4] - Hangya Technology plans to issue convertible bonds to raise up to 600 million CNY for various projects, including an intelligent manufacturing base in Malaysia [5] - Yuhua Development is publicly selling assets with a base price of 251 million CNY for residential properties [6] Group 3 - Penghui Energy plans to invest 2.1 billion CNY in a new battery production project in Zhengyang County, Henan Province, focusing on high-performance battery products [7] - Haige Communication's shareholder Yang Haizhou intends to reduce his stake by up to 0.1624% of the company's total shares [8] - Yaoshi Technology's controlling shareholder pledged 5.13% of shares to repay loans, with a pledge period from February 10, 2026, to February 2, 2027 [9][10] Group 4 - Hanyu Pharmaceutical received FDA approval for its drug Acetate Glatiramer Injection, used for treating relapsing multiple sclerosis [11] - Baiyao Tai's GoliMab Injection received EMA approval for various indications, including rheumatoid arthritis and ulcerative colitis [12] - Jiangxi Tungsten Equipment plans to issue A-shares to raise up to 1.882 billion CNY for acquisitions [13] Group 5 - Hesong New Materials expects to recognize asset impairment provisions between 23.6 million to 28.5 million CNY for 2025 [14] - ST Meichen's subsidiary is involved in two major lawsuits with a total amount of approximately 31.9 million CNY [15] - China Coal Energy reported a 7.3% year-on-year decline in coal sales for January 2026, with total sales of 20.05 million tons [16] Group 6 - Yida Co. plans to adjust its epoxy propylene derivative project, reducing the total investment from 845 million CNY to 642 million CNY [17] - Fosun Pharma's subsidiary received approval for a clinical trial of HLX15-SC for multiple myeloma treatment [18][19] - Yinfeng Communication's board members and executives have terminated their share reduction plan [20] Group 7 - Huazhong High-tech has waived its preferential purchase rights for a fund, extending the investment period from three to four years [21] - Warner Pharmaceuticals plans to participate in a national drug procurement program, with expected sales of 176 million CNY [22] - Changling Hydraulic announced a tender offer to acquire 12% of its shares at a price of 35.82 CNY per share [23] Group 8 - ST Chuan Zhi's stock may face delisting due to financial data falling below regulatory thresholds [24] - Tian Pharmaceutical and its subsidiaries are participating in a national drug procurement program, with expected sales of 323 million CNY [25] - China Metallurgical Group signed new contracts worth 73.65 billion CNY in January 2026 [26] Group 9 - Torus plans to invest 21.2 million CNY in a venture capital fund focused on artificial intelligence [27] - Shangwei Co. received a government subsidy of 1.764 million CNY, representing 10.79% of its net profit for 2024 [28] - Hanghua Co. reported a 21.97% decline in net profit for 2025, with total revenue of 1.249 billion CNY [29] Group 10 - Huaxia Bank reported a 1.72% decline in net profit for 2025, with total revenue of 91.914 billion CNY [30] - Guotou Fengle plans to transfer 51% of its stake in Hubei Fengle Ecological Fertilizer to optimize management [31] - Huaru Technology is co-investing in a fund with a total commitment of 20 million CNY [32] Group 11 - Jindike reported a loss of 173 million CNY for 2025, despite a 40.13% increase in revenue [33] - Zhenong Co. announced a 0.52% increase in shares held by a major shareholder [34] - Maike Audi plans to recognize asset impairment provisions of approximately 52.55 million CNY [35] Group 12 - Fuan Pharmaceutical's subsidiary is expected to be selected for a national drug procurement program, with projected sales of 680 million CNY [36] - Rundu Co. is participating in a national drug procurement program, with some products expected to be selected [37] - Changqing Co. has postponed its large-scale die-casting project to March 2027 due to customer requirements [38] Group 13 - Pan Asia Micro透 received a patent for a graphene-based automotive headlight defogging device [39] - Luan An Huan Neng reported a 17.1% increase in raw coal production for January 2026, totaling 5 million tons [40] - Guangji Pharmaceutical received a drug registration certificate for Mecobalamin Tablets [41] Group 14 - Ruifeng New Materials announced the resignation of its deputy general manager for personal reasons [42] - Zhiguang Electric's subsidiary signed a procurement contract for energy storage equipment worth 210.4 million CNY [43] - Youyan Powder Materials reported a 19.41% increase in net profit for 2025 [44] Group 15 - Jincheng reported a 22.2% increase in net profit for 2025, with total revenue of 253 million CNY [46]

本次投资符合公司的战略发展规划，为进一步优化公司产能布局，增强公司业务的影响力和综合竞争 力，满足公司未来业务发展和市场拓展的需要，对公司的产业布局及未来发展具有积极作用和深远意 义。 智通财经APP讯，鹏辉能源(300438.SZ)发布公告，为进一步优化公司产能布局，增强公司业务的影响力 和综合竞争力，公司拟在河南省正阳县投资建设年120Ah电芯生产项目，计划总投资金额21亿元。 ...

（记者 张明双） 每经AI快讯，鹏辉能源2月12日晚间发布公告称，公司第五届第二十一次董事会会议于2026年2月12日 在公司会议室以现场与通讯结合方式召开。会议审议了《关于在河南省正阳县投资建设120Ah电芯生产 项目的议案》等文件。 每经头条（nbdtoutiao）——打造百万元级尊界的江淮，迎来葛卫东、方文艳联手投资：两人各掏10亿 元，公司股价应声大涨！复盘历史：牛散参与定增有赚也有亏 ...